Literature DB >> 3455370

Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors.

T Pekkarinen1, M Partinen, R Pelkonen, M Iivanainen.   

Abstract

Sleep history and pituitary function were studied and sleep polygraphy performed in 11 acromegalic patients before and after pituitary surgery. Excessive daytime sleepiness or habitual snoring or both together, as well as an elevated fasting level of serum GH occurred in all the patients. In five men but in none of the women an abnormal number of episodes of sleep apnoea were observed. Pituitary adenomectomy improved the apnoea frequency in one patient, whereas in the others the abnormality was still present 1 year later. After operation the fasting level of serum GH became normal in eight patients, two of them with persisting sleep apnoea. The sleep apnoea syndrome is common and clinically important in acromegaly. Its early diagnosis using polygraphic monitoring is emphasized, as it is a treatable disorder.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3455370     DOI: 10.1111/j.1365-2265.1987.tb02947.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Prevalence of the sleep apnea syndrome in acromegaly population.

Authors:  V Weiss; K Sonka; M Pretl; S Dostálová; J Klozar; P Rambousek; J Marek; T Haas
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

2.  Polysomnography underestimates altered cardiac autonomic control in patients with obstructive sleep apnea.

Authors:  C Jilek; J Gebauer; F Muders; M Arzt; G Riegger; M Pfeifer; R Wensel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-03

3.  Screening of acromegaly in adults with obstructive sleep apnea: is it worthwhile?

Authors:  Pierre Attal; Philippe Chanson
Journal:  Endocrine       Date:  2018-05-22       Impact factor: 3.633

Review 4.  Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.

Authors:  Rosario Pivonello; Renata S Auriemma; Ludovica F S Grasso; Claudia Pivonello; Chiara Simeoli; Roberta Patalano; Mariano Galdiero; Annamaria Colao
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

5.  Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients.

Authors:  Cinzia Castellani; Giuseppe Francia; Luca Dalle Carbonare; Marcello Ferrari; Elena Viva; Roberto Cerini; Alessandro Zaccarella; Lorenzo Trevisiol; Maria Vittoria Davi'
Journal:  Endocrine       Date:  2015-06-21       Impact factor: 3.633

Review 6.  Epidemiology of acromegaly.

Authors:  I M Holdaway; C Rajasoorya
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

7.  Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed.

Authors:  Tirissa J Reid; Kalmon D Post; Jeffrey N Bruce; M Nabi Kanibir; Carlos M Reyes-Vidal; Pamela U Freda
Journal:  Clin Endocrinol (Oxf)       Date:  2009-05-16       Impact factor: 3.478

Review 8.  Pegvisomant in acromegaly: an update.

Authors:  A Giustina; G Arnaldi; F Bogazzi; S Cannavò; A Colao; L De Marinis; E De Menis; E Degli Uberti; F Giorgino; S Grottoli; A G Lania; P Maffei; R Pivonello; E Ghigo
Journal:  J Endocrinol Invest       Date:  2017-02-07       Impact factor: 4.256

9.  The Course of Obstructive Sleep Apnea Syndrome in Patients With Acromegaly During Treatment.

Authors:  Thalijn L C Wolters; Sean H P P Roerink; Linda C A Drenthen; Jolanda H G M van Haren-Willems; Margaretha A E M Wagenmakers; Johannes W A Smit; Adrianus R M M Hermus; Romana T Netea-Maier
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.